Stocks · News reference
The Oncology Institute (NASDAQ:TOI) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.06) by 33.33 percent. This is a 46.67 percent increase over losses of $(0.15) per
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Oncology Institute (NASDAQ:TOI) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This transcript is brought to you by Benzinga APIs. For real-time
Oncology Institute (NASDAQ:TOI) raises FY2026 sales outlook from $630.000 million-$650.000 million to $650.000 million-$670.000 million vs $651.941 million estimate.